EP Winer
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 43
- Cancer Treatment and Pharmacology 24
- HER2/EGFR in Cancer Research 15
- Cancer Diagnosis and Treatment 6
- Cancer Immunotherapy and Biomarkers 4
-
- Advanced Breast Cancer Therapies 17
- Co-authors
- JA Ligibel (4 shared papers)J. A. Sparano (1 shared paper)Craig A. Bunnell (3 shared papers)Anh Nguyen Duc (2 shared papers)Sylvia Adams (2 shared papers)Andreas Schneeweiß (2 shared papers)Sherene Loi (2 shared papers)Hiroji Iwata (2 shared papers)
- Journals
- Cancer Research (28 papers)Journal of Clinical Oncology (6 papers)European Journal of Cancer (4 papers)Annals of Oncology (3 papers)The Breast (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
EP Winer
47 papers receiving 557 citations
Peers
Comparison fields: 5 of 50
- Oncology 444
- Cancer Research 147
- Pulmonary and Respiratory Medicine 123
- Immunology 77
- Radiology, Nuclear Medicine and Imaging 57
Countries citing papers authored by EP Winer
This map shows the geographic impact of EP Winer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EP Winer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EP Winer more than expected).
Fields of papers citing papers by EP Winer
This network shows the impact of papers produced by EP Winer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EP Winer. The network helps show where EP Winer may publish in the future.
Co-authors
The 25 scholars most cited alongside EP Winer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 98 | |
| 2 | 2019 | 86 | |
| 3 | 2002 | 74 | |
| 4 | 2019 | 61 | |
| 5 | 2001 | 44 | |
| 6 | Oral 5-FU analogues in the treatment of breast cancer. | 1998 | 26 |
| 7 | 2003 | 23 | |
| 8 | 2009 | 14 | |
| 9 | 2011 | 13 | |
| 10 | Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer. | 1996 | 12 |
| 11 | 2005 | 11 | |
| 12 | 2009 | 10 | |
| 13 | 2013 | 10 | |
| 14 | 2019 | 9 | |
| 15 | 2020 | 9 | |
| 16 | 1997 | 9 | |
| 17 | 2004 | 8 | |
| 18 | 2010 | 6 | |
| 19 | 2001 | 6 | |
| 20 | 2011 | 5 |
About EP Winer
EP Winer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 51 papers that have together received 584 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (24 papers), Advanced Breast Cancer Therapies (17 papers), HER2/EGFR in Cancer Research (15 papers), Breast Cancer Treatment Studies (13 papers), Cancer Diagnosis and Treatment (6 papers), BRCA gene mutations in cancer (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Oncology (444 citations), Cancer Research (147 citations), Pulmonary and Respiratory Medicine (123 citations), Immunology (77 citations) and Radiology, Nuclear Medicine and Imaging (57 citations). EP Winer has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include JA Ligibel, J. A. Sparano, Craig A. Bunnell, Anh Nguyen Duc, Sylvia Adams, Andreas Schneeweiß, Sherene Loi, Hiroji Iwata, Peter Schmid and Luciana Molinero. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.